MS Counseling Points Winter 2017 : Page 2
FACULTY: Series Editor Amy Perrin Ross, APN, MSN, CNRN, MSCN Neuroscience Program Coordinator Loyola University Medical Center Maywood, IL Faculty Advisors Deanna Power, RN, MSCN, CNRN Clinical Nurse Specialist, Department of Neurology Sansum Clinic Santa Barbara, CA Leslie Tarlow, MSN, RN, GNP-BC, MSCN Nurse Practitioner, Department of Neurology Multiple Sclerosis Division Keck Medical Center University of Southern California Los Angeles, CA Faculty Disclosure Statements Amy Perrin Ross has received honoraria for participating on the Speakers’ Bureaus for Acorda, Bayer HealthCare, Inc., Biogen Idec, EMD Serono, Genzyme, Mallinckrodt, Novartis, Pfizer, and Teva Pharmaceuticals, and as a consultant for Acorda, Bayer HealthCare, Inc., EMD Serono, Genzyme, Mallinckrodt, Novartis, and Teva Pharmaceuticals. Deanna Power has disclosed no relevant financial relationships. Leslie Tarlow has received honoraria for participating on the Speakers’ Bureaus for Genentech and Genzyme and as a consultant for Biogen, Genentech, Genzyme, Novartis, and Teva Pharmaceuticals. Planners and Managers The following planners and managers have declared no relevant financial relationships: Joseph J. D’Onofrio, Frank Marino, Katherine Wandersee. Counseling Points ™ Managing Patient and Family Expectations in MS Continuing Education Information Target Audience This educational activity is designed to meet the needs of nurses who treat or who have an interest in patients with multiple sclerosis (MS). Purpose To provide nurses with information and practice advice related to patient counseling on up-to-date issues in multiple sclerosis management and daily living. Learning Objectives Upon completion of this educational activity, the participant should be able to: • Discuss current findings affecting patients’ expectations for therapeutic outcomes • Describe how patient expectations influence adherence to MS therapies • Develop counseling strategies to help patients manage expectations specific to their individual disease course and health status Continuing Education Credit This continuing nursing education activity is developed under the joint providership of Delaware Media Group and NP Alternatives. NP Alternatives (NPA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. NPA designates this enduring material for a maximum of 1.0 Continuing Nursing Education Credits. Laurie Scudder, DNP, NP, served as Nurse Planner and reviewer for this activity. She has declared no relevant financial relationships. In order to earn credit, please read the entire activity and complete the posttest and evaluation at the end. Approximate time to complete this activity is 60 minutes. This program expires January 31, 2019. PUBLISHING INFORMATION: Publishers Joseph J. D’Onofrio Frank M. Marino Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 Tel: 201-612-7676 Fax: 201-612-8282 Websites: www.delmedgroup.com www.counselingpoints.com Medical Writer Katherine Wandersee Art Director James Ticchio Cover photo credit: © Capifrutta / Thinkstock Disclosure of Unlabeled Use This CNE activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. NPA, Delaware Media Group, and the sup-porters (Sanofi Genzyme and Teva Pharmaceuticals) do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activ-ity are those of the faculty and do not necessarily represent the views of NPA, Delaware Media Group, Sanofi Genzyme, or Teva Pharmaceuticals. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evalu-ating their patients’ conditions, considering possible contraindications or risks, review-ing any applicable manufacturer’s product information, and comparing any therapeu-tic approach with the recommendations of other authorities. 2 Copyright © 2017, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or rec-ommendations of their affiliated institutions, the publisher, Sanofi Genzyme, or Teva Pharmaceuticals. www . counselingpoints . com
Continuing Education Information
Read the full article at http://digitaledition.qwinc.com/article/Continuing+Education+Information/2705947/382068/article.html.